Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Front-line combination treatments in GU malignancies: How do we decide?

Q&A and discussion

Date

03 Dec 2022

Session

Front-line combination treatments in GU malignancies: How do we decide?

Presenters

Masatoshi Eto

Authors

M. Eto

Author affiliations

  • Kyushu University - Graduate School of Medical Sciences - Faculty of Medical Sciences, 812-8582 - Fukuoka/JP

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Renal cell carcinoma (RCC)

Presenter: Lisa Pickering

Session: Front-line combination treatments in GU malignancies: How do we decide?

Resources:

Slides

Webcast

Urothelial cancer

Presenter: Enrique Grande Pulido

Session: Front-line combination treatments in GU malignancies: How do we decide?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.